Abstract
Primary biliary cirrhosis (PBC), which predominantly affects women, has been associated with various autoimmune diseases. Although hypothyroidism accompanying PBC is well documented, the concomitance of PBC and hyperthyroidism is rare. Herein, we report the case of a 62-year-old man who was diagnosed with PBC several years after the development of Graves’ disease. This is the first case of a male patient developing PBC with Graves’ disease. Both serum alanine aminotransferase levels and serum thyroid hormone levels were normalized after the administration of thiamazole for Graves’ disease. However, the cholestatic liver enzyme abnormalities continued, indicating that the PBC was actualized by the administration of thiamazole. After starting ursodeoxycholic acid treatment, cholestatic liver enzyme abnormalities improved. Taken together, when a cholestatic pattern of liver enzymes is observed during follow-up for Graves’ disease, an association between Graves’ disease and PBC should be considered as a differential diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261–73.
Invernizzi P, Battezzati PM, Crosignani A, et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol. 2003;38:401–6.
Gershwin ME, Selmi C, Worman HJ, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005;42:1194–202.
Floreani A, Franceschet I, Cazzagon N, et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol. 2015;48:192–7.
Elta GH, Sepersky RA, Goldberg MJ, et al. Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci. 1983;28:971–5.
Thompson NP, Leader S, Jamieson CP, et al. Reversible jaundice in primary biliary cirrhosis due to hyperthyroidism. Gastroenterology. 1994;106:1342–3.
Floreani A, Caroli A, Chiaramonte M, et al. Hyperthyroidism associated with primary cirrhosis. Two case reports. Recent Prog Med. 1989;80:582–3.
Cooper DS. Hyperthyroidism. Lancet. 2003;362:459–68.
Nieri S, Riccardo GG, Salvadori G, et al. Primary biliary cirrhosis and Graves’ disease. J Clin Gastroenterol. 1985;7:434–7.
Iikuni N, Hanzawa M, Ohta S, et al. A rare case of systemic sclerosis complicated with multiple autoimmune diseases (Sjögren’s syndrome, Graves’ disease, and primary biliary cirrhosis). Mod Rheumatol. 2004;14:476–9.
Nakamura T, Higashi S, Tomada K, et al. Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjögren’s syndrome and thyroid dysfunction. Clin Rheumatol. 2007;26:596–600.
Yaşar DG, Ozenirler S, Doğan M. A patient with primary biliary cirrhosis accompanied by Graves’ disease and Hurthle cell adenoma. Turk J Gastroenterol. 2007;18:198–200.
Shetty S, Rajasekaran S, Venkatakrishnan L. Grave’s disease and primary biliary cirrhosis—an unusual and challenging association. J Clin Exp Hepatol. 2014;4:66–7.
Fong TL, McHutchison JG, Reynolds TB. Hyperthyroidism and hepatic dysfunction. A case series analysis. J Clin Gastroenterol. 1992;14:240–4.
Nalbandian G, Van de Water J, Gish R. Is there a serological difference between men and women with primary biliary cirrhosis? Am J Gastroenterol. 1999;94:2482–6.
Selmi C, Meda F, Kasangian A, et al. Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol. 2010;7:1–10.
Lucey MR, Neuberger JM, Williams R. Primary biliary cirrhosis in men. Gut. 1986;27:1373–6.
Melia WM, Johnson PJ, Neuberger J, et al. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation. Gastroenterology. 1984;87:660–3.
Juran BD, Atkinson EJ, Schlicht EM, et al. Primary biliary cirrhosis is associated with a genetic variant in the 3′ flanking region of the CTLA4 gene. Gastroenterology. 2008;135:1200–6.
Kouki T, Sawai Y, Gardine CA, et al. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’s disease. J Immunol. 2000;165:6606–11.
Umemura T, Joshita S, Ichijo T, et al. Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis. Hepatology. 2012;55:506–11.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest:
The authors declare that they have no conflict of interest in relation to this study.
Human/Animal Rights:
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later amendments.
Informed Consent:
Informed consent was obtained from all patients included in the study.
Rights and permissions
About this article
Cite this article
Suzuki, Y., Ishida, K., Takahashi, H. et al. Primary biliary cirrhosis associated with Graves’ disease in a male patient. Clin J Gastroenterol 9, 99–103 (2016). https://doi.org/10.1007/s12328-016-0635-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-016-0635-x